Galapagos NV. announced its plans to split into two listed entities by mid-2025 by spinning off its activities focused on ...
LONDON — The beleaguered Belgian firm Galapagos NV said Wednesday it would split itself into two companies, with the brand-name biotech aiming ... branch now known as SpinCo, plans to build ...
Final Synthetic Yeast Chromosome Unlocks New Era in Biotechnology Jan. 22, 2025 — Scientists have completed construction of the final chromosome in the worlds' first synthetic yeast genome ...
Belgian biotech company Galapagos NV plans to spin ... The newly formed company, preliminarily called SpinCo, will apply to have its shares listed on Euronext, according to a statement on Wednesday.
From red carpets to resident aliens and driving ranges, NBCUniversal’s SpinCo has given its first indication what its programming strategy might look like with the hire of Val Boreland as ...
Carmell acquires Elevai Skincare, adding $2.5M in annual revenue and advanced exosome technology to its portfolio. Deal includes $1.1M in equity, $57K in cash, and earnouts tied to sales and ...
A new year means a new Fierce Biotech Fundraising Tracker to record all the venture capital being funneled into the industry for 2024. We're bumping up our reporting criteria from last year's ...
Looking for the best biotech penny stocks? The most important innovation of the 1990s was the internet — today, it would be a vaccine for COVID-19. If these times have anything to say about it ...
Comcast’s SpinCo has set its future leadership team as the company prepares to spin off its cable television network portfolio later this year. The company previously announced that SpinCo would ...
From red carpets to resident aliens and driving ranges, NBCUniversal’s SpinCo has given its first indication what its programming strategy might look like with the hire of Val Boreland as President of ...
I am thrilled to be joined by such a talented group of leaders with the experience and expertise needed to make SpinCo a leading multimedia company from day one,” said Mark Lazarus.